Thorne HealthTech Target Price vs. Book Value Per Share

THRNDelisted Stock  USD 6.40  0.48  8.11%   
Considering the key profitability indicators obtained from Thorne HealthTech's historical financial statements, Thorne HealthTech may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Thorne HealthTech's ability to earn profits and add value for shareholders.
For Thorne HealthTech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Thorne HealthTech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Thorne HealthTech utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Thorne HealthTech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Thorne HealthTech over time as well as its relative position and ranking within its peers.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Please note, there is a significant difference between Thorne HealthTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thorne HealthTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thorne HealthTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Thorne HealthTech Book Value Per Share vs. Target Price Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Thorne HealthTech's current stock value. Our valuation model uses many indicators to compare Thorne HealthTech value to that of its competitors to determine the firm's financial worth.
Thorne HealthTech is rated below average in target price category among its peers. It also is rated below average in book value per share category among its peers creating about  0.36  of Book Value Per Share per Target Price. The ratio of Target Price to Book Value Per Share for Thorne HealthTech is roughly  2.80 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Thorne HealthTech's earnings, one of the primary drivers of an investment's value.

Thorne Book Value Per Share vs. Target Price

Thorne HealthTech

 = 
6.9
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Thorne HealthTech

Book Value per Share

 = 

Common Equity

Average Shares

 = 
2.46 X
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.

Thorne Book Value Per Share Comparison

Thorne HealthTech is currently under evaluation in book value per share category among its peers.

Thorne HealthTech Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Thorne HealthTech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Thorne HealthTech will eventually generate negative long term returns. The profitability progress is the general direction of Thorne HealthTech's change in net profit over the period of time. It can combine multiple indicators of Thorne HealthTech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally. Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York. Thorne Healthtech operates under Packaged Foods classification in the United States and is traded on NASDAQ Exchange. It employs 496 people.

Thorne Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Thorne HealthTech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Thorne HealthTech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Thorne HealthTech's important profitability drivers and their relationship over time.

Use Thorne HealthTech in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Thorne HealthTech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Thorne HealthTech will appreciate offsetting losses from the drop in the long position's value.

Thorne HealthTech Pair Trading

Thorne HealthTech Pair Trading Analysis

The ability to find closely correlated positions to Thorne HealthTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Thorne HealthTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Thorne HealthTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Thorne HealthTech to buy it.
The correlation of Thorne HealthTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Thorne HealthTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Thorne HealthTech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Thorne HealthTech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Thorne HealthTech position

In addition to having Thorne HealthTech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Rentals Thematic Idea Now

Rentals
Rentals Theme
Companies providing rental and leasing services to public and business. The Rentals theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rentals Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Thorne Stock

If you are still planning to invest in Thorne HealthTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Thorne HealthTech's history and understand the potential risks before investing.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Stocks Directory
Find actively traded stocks across global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk